Tomas C. Pascoa

Tomas C. Pascoa

Auto-generated profile, based on publicly available information

Tomas C. Pascoa

Department of Chemistry and Center for Synthetic Microbiology (SYNMIKRO), Philipps-University Marburg, Marburg, Germany

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2021 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
LNLaiyin Nie
Laiyin Nie
TPTomas C. Pascoa
Tomas C. Pascoa
APAshley C. W. Pike
Ashley C. W. Pike
SBSimon R. Bushell
Simon R. Bushell
AQAndrew Quigley
Andrew Quigley
ECElisabeth P. Carpenter
Elisabeth P. Carpenter

15 November 2017 in ACS Nano
Verified
Journal Article
Closed access
BCBenjamin Cressiot
Benjamin Cressiot
SGSandra J. Greive
Sandra J. Greive
WSWei Si
Wei Si
TPTomas C. Pascoa
Tomas C. Pascoa
MMMehrnaz Mojtabavi
Mehrnaz Mojtabavi
MWMeni Wanunu
Meni Wanunu

11 November 2024 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
PDF file
TPTomas C. Pascoa
Tomas C. Pascoa
APAshley C. W. Pike
Ashley C. W. Pike
CTChristofer S Tautermann
Christofer S Tautermann
GCGamma Chi
Gamma Chi
MTMichael Traub
Michael Traub
DSDavid B. Sauer
David B. Sauer
Ceramides are bioactive sphingolipids crucial for regulating cellular metabolism. Ceramides and dihydroceramides are synthesized by six ceramide synthase (CerS) enzymes, each with specificity for different acyl-CoA substrates. Ceramide with a 16-carbon acyl chain (C16 ceramide) has been implicated in obesity, insulin resistance and liver disease and the C16 ceramide-synthesizing CerS6 is regarded as an attractive drug target for obesity-associated disease. Despite their importance, the molecular mechanism underlying ceramide synthesis by CerS enzymes remains poorly understood. Here we report cryo-electron microscopy structures of human CerS6, capturing covalent intermediate and product-bound states. These structures, along with biochemical characterization, reveal that CerS catalysis proceeds through a ping-pong reaction mechanism involving a covalent acyl–enzyme intermediate. Notably, the product-bound structure was obtained upon reaction with the mycotoxin fumonisin B1, yielding insights into its inhibition of CerS. These results provide a framework for understanding CerS function, selectivity and inhibition and open routes for future drug discovery.

2 December 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
TPTomas C. Pascoa
Tomas C. Pascoa
APAshley C.W. Pike
Ashley C.W. Pike
CTChristofer S Tautermann
Christofer S Tautermann
GCGamma Chi
Gamma Chi
MTMichael Traub
Michael Traub
DSDavid B. Sauer
David B. Sauer
Ceramides are bioactive sphingolipids that play pivotal roles in regulating cellular metabolism. Ceramides and dihydroceramides are synthesized by a family of six ceramide synthase enzymes (CerS), each with distinct specificity for the acyl-CoA substrate. Importantly, the acyl chain length plays a key role in determining the physiological function of ceramides, as well as their role in metabolic disease. Ceramide with an acyl chain length of 16 carbons (C16 ceramide) has been implicated in obesity, insulin resistance and liver disease, and the C16 ceramide-synthesizing CerS6 is regarded as an attractive drug target for obesity-associated disease. Despite their importance, the molecular mechanism underlying ceramide synthesis by CerS enzymes remains poorly understood. Here, we report cryo-electron microscopy structures of human CerS6, capturing covalent intermediate and product-bound states. These structures, together with biochemical characterization using intact protein and small molecule mass spectrometry, reveal that CerS catalysis proceeds via a ping-pong reaction mechanism involving a covalent acyl-enzyme intermediate. Notably, the product-bound structure was obtained upon reaction with the mycotoxin fumonisin B 1 , providing new insights into its inhibition of CerS. These results provide a framework for understanding the mechanisms of CerS function, selectivity, and inhibition, and open new directions for future drug discovery targeting the ceramide and sphingolipid pathways.

3 June 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
TRTristan Reif-Trauttmansdorff
Tristan Reif-Trauttmansdorff
EHEva Herdering
Eva Herdering
SBStefan Bohn
Stefan Bohn
TPTomas Pascoa
Tomas Pascoa
JKJörg Kahnt
Jörg Kahnt
JSJan M. Schuller
Jan M. Schuller
Methanogenic archaea contribute 1–2 Gt of methane annually, impacting both global carbon cycling and climate. Central to their energy metabolism is a membrane-bound, sodium-translocating methyltransferase complex: the N⁵-tetrahydromethanopterin:CoM-S-methyltransferase (Mtr complex), which catalyzes the methyl transfer between two methanogen specific cofactors. This exergonic methyl transfer step is coupled with a vectorial sodium ion transport from the cytoplasm to the cell exterior and is the only energy conserving step in hydrogenotrophic methanogenesis. Here, we present a 2.1 Å single-particle cryo-EM structure of the full Mtr complex from Methanosarcina mazei . Our structural model encompasses the entire complex, reveals the arrangement of archaeal phospholipids, the architecture of the sodium ion binding site, and the structure and interactions of all catalytic subunits. Most strikingly, we discover and characterize MtrI, a previously unannotated small open reading frame (small ORF), encoded protein (<100 aa) conserved across the order of Methanosarcinales. MtrI binds to the cytoplasmic domain of MtrA in response to oxygen exposure, suggesting a role in oxygen stress response and protection. By binding on top of the sodium channel and anchoring to the cobamide cofactor in MtrA’s cytoplasmic domain, MtrI might prevent sodium leakage and inhibit MtrA-CoM turnover. These findings offer new insights into methanogen energy conservation and uncover a potential adaptive response to oxygen exposure, expanding our understanding of methanogen survival strategies under oxidative stress.

13 April 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
LALena Appel
Lena Appel
AKAnuj Kumar
Anuj Kumar
DTDavide Tamborrini
Davide Tamborrini
TPTomas C. Pascoa
Tomas C. Pascoa
KKKanwal Kayastha
Kanwal Kayastha
MBMatthias Boll
Matthias Boll
Microbial degradation of ubiquitous aromatic compounds is central to the global carbon cycle and bioremediation, yet the intrinsic stability of aromatic rings poses a major barrier to their breakdown. Under strictly anaerobic conditions, class II benzoyl-CoA reductases (BCRII) catalyse the key step of this process, a Birch-like reduction of the aromatic ring to a cyclic diene at a tungsten cofactor. This reaction operates beyond the redox limits of conventional biological electron transfer, yet the mechanism by which BCRII generates such extreme reducing power has remained unclear. Here, high-resolution cryo-electron microscopy, in situ cryo-electron tomography, and enzymatic analyses reveal that the one-MDa BCRII complex from Geobacter metallireducens links two distinct flavin-based electron-bifurcation modules, previously characterised in hydrogenases and heterodisulfide reductases, to drive aromatic ring reduction. Reduced ferredoxin and NADH deliver electrons through sequential confurcation and bifurcation to the catalytic site, while cryo-electron tomography of native cells identifies electron-transferring flavoprotein as the second acceptor directing high-potential electrons into the respiratory chain. These results show that modular FBEB units can be hierarchically assembled to extend metabolic redox capacity, highlighting their versatility as adaptable components for electron transfer pathways.